Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

NCT00950417 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Advanced Esophageal

Interventions

DRUG: Nimotuzumab

Sponsor

Biotech Pharmaceutical Co., Ltd.